Inventor · disambiguated record
David C. Cipolla
Also filed as: CIPOLLA DAVID · CIPOLLA DAVID C
21 granted patents·14 pending applications·445 citations·filing 1993–2022
96Inventor score
Top patents by PatentIndex Score
35 records- 0197US9078897B1Concentrated, inhalable antibiotic formulationARADIGM CORP·Filed 2015·Granted Jul 14, 2015·26 cites·2 claims
- 0297US8071127B2Dual action, inhaled formulations providing both an immediate and sustained release profileCIPOLLA DAVID C·Filed 2008·Granted Dec 6, 2011·42 cites·20 claims
- 0396US9259424B2Concentrated, inhalable antibiotic formulationARADIGM CORP·Filed 2014·Granted Feb 16, 2016·25 cites·21 claims
- 0496US8119156B2Dual action, inhaled formulations providing both an immediate and sustained release profileCIPOLLA DAVID C·Filed 2009·Granted Feb 21, 2012·40 cites·10 claims
- 0595US9028864B2Concentrated, inhalable antibiotic formulationCIPOLLA DAVID C·Filed 2010·Granted May 12, 2015·25 cites·1 claims
- 0695US8414915B2Dual action, inhaled formulations providing both an immediate and sustained release profileCIPOLLA DAVID C·Filed 2012·Granted Apr 9, 2013·42 cites·14 claims
- 0795US8268347B1Dual action, inhaled formulations providing both an immediate and sustained release profileCIPOLLA DAVID C·Filed 2007·Granted Sep 18, 2012·47 cites·23 claims
- 0885US9844548B2Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystalsARADIGM CORP·Filed 2016·Granted Dec 19, 2017·3 cites·28 claims
- 0984US5829435APrefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particlesARADIGM CORP·Filed 1997·Granted Nov 3, 1998·99 cites·40 claims
- 1081US9545401B2Concentrated, inhalable ciprofloxacin formulationCIPOLLA DAVID C·Filed 2011·Granted Jan 17, 2017·3 cites·24 claims
- 1180US5945402AHuman relaxin formulationGENENTECH INC·Filed 1995·Granted Aug 31, 1999·30 cites·16 claims
- 1275US9987227B2Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profileARADIGM CORP·Filed 2014·Granted Jun 5, 2018·2 cites·16 claims
- 1372US11026941B2Concentrated, inhalable ciprofloxacin formulationGRIPOLS S A·Filed 2019·Granted Jun 8, 2021·0 cites·16 claims
- 1471US5770152ACollapsible container for measuring particles in a sample fluidARADIGM CORP·Filed 1996·Granted Jun 23, 1998·30 cites·4 claims
- 1568US11116765B2Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteriaGRIFOLS SA·Filed 2020·Granted Sep 14, 2021·0 cites·15 claims
- 1668US5451572AHuman relaxin formulationGENENTECH INC·Filed 1993·Granted Sep 19, 1995·28 cites·25 claims
- 1767US2008138397A1Processes for taste-masking of inhaled formulationsARADIGM CORP·Filed 2007·Application pending·0 cites
- 1865US2020297722A1pH-Modulated Formulations for Pulmonary DeliveryGRIFOLS SA·Filed 2020·Application pending·0 cites
- 1964US10420765B2Concentrated, inhalable ciprofloxacin formulationARADIGM CORP·Filed 2016·Granted Sep 24, 2019·0 cites·17 claims
- 2064US2019328731A1Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteriaARADIGM CORP·Filed 2019·Application pending·0 cites
- 2163US10376508B2Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteriaARADIGM CORP·Filed 2017·Granted Aug 13, 2019·0 cites·16 claims
- 2259US2025049813A1Certain n-(1-cyan0-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating chronic rhinosinusitisINSMED INC·Filed 2022·Application pending·0 cites
- 2357US2023310453A1Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditionsINSMED INC·Filed 2021·Application pending·0 cites
- 2454US9532986B2Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteriaARADIGM CORP·Filed 2015·Granted Jan 3, 2017·0 cites·9 claims
- 2553US2012177693A1Deep lung pulmonary delivery of treprostinilCIPOLLA DAVID C·Filed 2009·Application pending·0 cites
- 2652US2016331744A1pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERYARADIGM CORP·Filed 2016·Application pending·0 cites
- 2748US2010209538A1Ph-modulated formulations for pulmonary deliveryCIPOLLA DAVID C·Filed 2010·Application pending·0 cites
- 2846US2011104259A1Processes for taste-masking of inhaled formulationsARADIGM CORP·Filed 2011·Application pending·0 cites
- 2946US2021007985A1Liposomal anti-infective formulations to inhibit non-tuberculous mycobacteria (ntm) microaggregate formation and establishment of ntm biofilmARADIGM CORP·Filed 2018·Application pending·0 cites
- 3043US2016120806A1Nanocrystals formed in a microenvironmentARADIGM CORP·Filed 2016·Application pending·0 cites
- 3143US2005263149A1Aerosol drug delivery system employing formulation pre-heatingNOYMER PETER D·Filed 2005·Application pending·0 cites
- 3242US9968555B2Liposomal formulations that form drug nanocrystals after freeze-thawARADIGM CORP·Filed 2015·Granted May 15, 2018·0 cites·15 claims
- 3340US2010228225A1Method and system for delivery of neurotoxinsCIPOLLA DAVID·Filed 2007·Application pending·0 cites
- 3439US2004055595A1Aerosol drug delivery system employing formulation pre-heatingFiled 2002·Application pending·0 cites
- 3532US5457044AMethod for collection of aerosolized proteins by inert filtrationGENENTECH INC·Filed 1993·Granted Oct 10, 1995·3 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when David C. Cipolla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →